Skip to main content
CARL logo
CARL
(NASDAQ)
Carlsmed, Inc.
$9.73-- (--)
Loading... - Market loading

Carlsmed (CARL) Income Statement

Revenue, expenses, profit margins, and earnings with annual and quarterly data.

Carlsmed Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Carlsmed, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023
Period EndingDec 2025Dec 2024Dec 2023
Revenue & Gross Profit
Revenue50.5127.1713.78
Cost of Revenue12.477.123.88
Gross Profit38.0420.059.90
Operating Expenses
Research & Development17.0214.307.40
Selling, General & Administrative51.6029.8721.10
Operating Expenses68.6144.1728.49
Operating Income-30.57-24.12-18.59
Other Income/Expense
Interest Income2.701.330.33
Interest Expense-1.431.320.64
Other Income/Expense-0.33-0.14-0.31
Income
Income Before Tax-29.63-24.26-18.90
Income Tax Expense0.000.000.00
Net Income-29.63-24.26-18.90
Net Income - Continuous Operations-29.63-24.26-18.90
Net Income - Discontinued Operations0.000.000.00
EBITDA-30.29-22.79-18.12
EBIT-30.57-22.94-18.26
Depreciation & Amortization0.280.150.14
Earnings Per Share
Basic EPS-2.00-6.00-4.00
Diluted EPS-2.00-6.00-4.00
Basic Shares Outstanding14.224.074.45
Diluted Shares Outstanding14.224.074.45

These financial metrics are calculated using income statement data. Learn how each metric works and screen stocks by them.